RP11‐81H3.2 promotes gastric cancer progression through miR‐339‐HNRNPA1 interaction network

Autor: Miao An, Fenrong Chen, Yan Wang, Su-Mei Sha, Dong Liu, Jun Zhang, Shen-hao Wang, Yan Cheng, Haitao Shi, Lei Dong
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Cancer Research
Heterogeneous Nuclear Ribonucleoprotein A1
Apoptosis
Metastasis
Mice
0302 clinical medicine
Cell Movement
Tumor Cells
Cultured

Original Research
Cancer Biology
Mice
Inbred BALB C

HNRNPA1
Gene knockdown
Chemistry
Middle Aged
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Gene Expression Regulation
Neoplastic

Survival Rate
Oncology
030220 oncology & carcinogenesis
Female
RNA
Long Noncoding

RP11‐81H3.2
Mice
Nude

miR‐339
lcsh:RC254-282
03 medical and health sciences
Stomach Neoplasms
In vivo
microRNA
Biomarkers
Tumor

medicine
Animals
Humans
Protein Interaction Domains and Motifs
Radiology
Nuclear Medicine and imaging

Cell Proliferation
tumor metastasis
Oncogene
Cell growth
gastric cancer
Cancer
medicine.disease
Xenograft Model Antitumor Assays
eye diseases
MicroRNAs
030104 developmental biology
Cell culture
Cancer research
Zdroj: Cancer Medicine, Vol 9, Iss 7, Pp 2524-2534 (2020)
Cancer Medicine
ISSN: 2045-7634
DOI: 10.1002/cam4.2867
Popis: Recent studies have demonstrated that various long non‐coding RNAs (lncRNAs) participate in the gastric cancer (GC) development and metastasis. Some lncRNAs exert their regulatory function by interacting with microRNAs. Here we identified a novel lncRNA RP11‐81H3.2 that was highly expressed in the GC tissue and cell lines. RP11‐81H3.2 knockdown significantly inhibited the proliferation, migration, and invasion of GC cells. Mechanistically, we demonstrated that RP11‐81H3.2 directly interacted with miR‐339 while miR‐339 regulated the HNRNPA1 expression by targeting HRRNPA1 3’‐UTR. RP11‐81H3.2‐miR‐339‐HNRNPA1 interaction network regulated the GC cell proliferation, migration, and invasion. Moreover, our results confirmed that RP11‐81H3.2 knockdown suppressed the tumor growth of GC in a xenograft model in vivo. In summary, the results suggest that RP11‐81H3.2 functions as an oncogene in GC and could be utilized as a promising diagnosis and therapeutic marker for GC treatment.
LncRNA RP11‐81H3.2 is highly expressed in gastric cancer tissues and cell lines. Knockdown of lncRNA RP11‐81H3.2 suppresses gastric tumor growth in a xenograft tumor model. RP11‐81H3.2/miR‐339/HNRNPA1 interaction network regulates gastric cancer development and progession.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje